Surgical outcomes of patients with iridocorneal endothelial syndrome: a case series

The purpose of this study is to report the intermediate-term surgical outcomes of patients with iridocorneal endothelial syndrome-related glaucoma. The medical records of four patients (five eyes) surgery (Ahmed glaucoma valve implantation surgery and EX-PRESS mini shunt) were retrospectively reviewed. Median follow-up after glaucoma surgery was 24 (15–36) months. The preoperative intraocular pressure was significantly reduced from a median of 33 (22.5–36) mmHg on a median of 4 (4–5) glaucoma medications to a median of 12 (10.5–14.5) mmHg on a median of 2 (0–2) medications at last follow-up after surgery (p = 0.043 for IOP and p = 0.042 for glaucoma medications). Median preoperative visual acuity [0.016 (0.008–0.1)] did not change significantly when compared to median visual acuity at last follow-up [0.016 (0.004–0.5)] (p = 0.59). Intraocular pressure control in patients with iridocorneal endothelial syndrome is challenging and may require multiple operations and revisions. Some modifications during glaucoma drainage implant surgery and use of EX-PRESS mini shunt in certain cases could offer an advantage in these patients.